TransMedics Group, Inc.
TMDX
$122.52
$0.41270.34%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 274.54% | 62.64% | -65.43% | -0.02% | 202.58% |
| Total Depreciation and Amortization | 8.05% | 9.72% | 12.57% | 6.90% | 19.33% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -24.94% | 48.72% | -0.40% | 7.18% | 31.07% |
| Change in Net Operating Assets | -661.32% | 48.16% | -6,455.37% | 100.63% | -405.41% |
| Cash from Operations | -114.52% | 186.76% | -73.34% | 848.70% | -141.37% |
| Capital Expenditure | -98.72% | 71.77% | -102.85% | 46.20% | -5.63% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -100.00% | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -98.72% | 71.51% | -100.99% | 46.20% | -5.63% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 155.31% | -84.91% | -26.12% | 234.10% | 244.70% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 155.31% | -84.91% | -26.12% | 234.10% | 244.70% |
| Foreign Exchange rate Adjustments | 152.11% | -277.98% | 722.58% | 64.16% | -159.25% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -504.32% | 120.08% | -360.55% | 128.11% | -38.07% |